372 related articles for article (PubMed ID: 18620091)
1. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
Wagh PK; Peace BE; Waltz SE
Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
[TBL] [Abstract][Full Text] [Related]
2. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541
[TBL] [Abstract][Full Text] [Related]
3. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
Peace BE; Hughes MJ; Degen SJ; Waltz SE
Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
[TBL] [Abstract][Full Text] [Related]
5. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
[TBL] [Abstract][Full Text] [Related]
6. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
7. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
Feres KJ; Ischenko I; Hayman MJ
Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
[TBL] [Abstract][Full Text] [Related]
8. Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
Leonis MA; Thobe MN; Waltz SE
Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719
[TBL] [Abstract][Full Text] [Related]
9. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.
Jiang WG; Ye L; Ablin RJ; Kynaston HG; Mason MD
Int J Oncol; 2010 Aug; 37(2):413-8. PubMed ID: 20596668
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
Wang MH; Zhou YQ; Chen YQ
Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
12. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.
Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE
Cancer Res; 2006 Dec; 66(24):11967-74. PubMed ID: 17178895
[TBL] [Abstract][Full Text] [Related]
13. MSP-RON signalling in cancer: pathogenesis and therapeutic potential.
Yao HP; Zhou YQ; Zhang R; Wang MH
Nat Rev Cancer; 2013 Jul; 13(7):466-81. PubMed ID: 23792360
[TBL] [Abstract][Full Text] [Related]
14. An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.
Hunt BG; Fox LH; Davis JC; Jones A; Lu Z; Waltz SE
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833444
[TBL] [Abstract][Full Text] [Related]
15. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.
McClaine RJ; Marshall AM; Wagh PK; Waltz SE
Neoplasia; 2010 Aug; 12(8):650-8. PubMed ID: 20689759
[TBL] [Abstract][Full Text] [Related]
16. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
Thomas RM; Toney K; Fenoglio-Preiser C; Revelo-Penafiel MP; Hingorani SR; Tuveson DA; Waltz SE; Lowy AM
Cancer Res; 2007 Jul; 67(13):6075-82. PubMed ID: 17616662
[TBL] [Abstract][Full Text] [Related]
17. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis.
Gurusamy D; Ruiz-Torres SJ; Johnson AL; Smith DA; Waltz SE
Mech Dev; 2014 Aug; 133():11-22. PubMed ID: 25049204
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
Danilkovitch-Miagkova A
Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
[TBL] [Abstract][Full Text] [Related]
20. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
